Review



cxcl10  (Multi Sciences (Lianke) Biotech Co Ltd)


Bioz Verified Symbol Multi Sciences (Lianke) Biotech Co Ltd is a verified supplier
Bioz Manufacturer Symbol Multi Sciences (Lianke) Biotech Co Ltd manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Multi Sciences (Lianke) Biotech Co Ltd cxcl10
    Cxcl10, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/EasyGo!+Human+CXCL10%2FIP-10+One-Step+ELISA+Kit/pm41577074-231-30-32
    Average 94 stars, based on 1 article reviews
    cxcl10 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica
    Article Snippet: .. The sera of 28 patients with active PMR, 26 patients with PMR in remission, 24 patients with active RA, and 24 healthy check-ups were screened for differently expressed CXCL10 by quantitative detection using ELISA, the Human CXCL10/IP-10 ELISA Kit (EK168-96) was purchased from Multi Sciences, and the operation was carried out in accordance with the instruction manual, and duplicate wells were set up for each sample. .. SPSS 25.0® statistical software was used for analysis.

    Article Title: Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
    Article Snippet: .. ELISA validation of the differently expressed chemokine CXCL10 The sera of 28 patients with active PMR, 26 patients with PMR in remission, 24 patients with active RA, and 24 healthy check-ups were screened for differently expressed CXCL10 by quantitative detection using ELISA, the Human CXCL10/IP-10 ELISA Kit (EK168-96) was purchased from Multi Sciences, and the operation was carried out in accordance with the instruction manual, and duplicate wells were set up for each sample. .. SPSS 25.0® statistical software was used for analysis.

    Article Title: GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV
    Article Snippet: .. Human CXCL9/MIG ELISA kit (Multi Sciences, China) and human CXCL10/IP-10 ELISA kit (Multi Sciences, China) were used, following the manufacturer's instructions. ..

    Biomarker Discovery:

    Article Title: Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
    Article Snippet: .. ELISA validation of the differently expressed chemokine CXCL10 The sera of 28 patients with active PMR, 26 patients with PMR in remission, 24 patients with active RA, and 24 healthy check-ups were screened for differently expressed CXCL10 by quantitative detection using ELISA, the Human CXCL10/IP-10 ELISA Kit (EK168-96) was purchased from Multi Sciences, and the operation was carried out in accordance with the instruction manual, and duplicate wells were set up for each sample. .. SPSS 25.0® statistical software was used for analysis.



    Similar Products

    cxcl10  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd cxcl10
    Cxcl10, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/EasyGo!+Human+CXCL10%2FIP-10+One-Step+ELISA+Kit/pm41577074-231-30-32
    Average 94 stars, based on 1 article reviews
    cxcl10 - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    elisa kits  (Proteintech)
    94
    Proteintech elisa kits
    Elisa Kits, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+ELISA+Kit/10__1186_slash_s12964___026___03195___2-326-22-27
    Average 94 stars, based on 1 article reviews
    elisa kits - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    cxcl10  (Elabscience Biotechnology)
    94
    Elabscience Biotechnology cxcl10
    Cxcl10, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+IP-10%2FCXCL10+(Interferon+Gamma+Induced+Protein+10kDa)+ELISA+Kit/pmc13685605-244-15-21
    Average 94 stars, based on 1 article reviews
    cxcl10 - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    dip100 quantikine immunoassay  (R&D Systems)
    96
    R&D Systems dip100 quantikine immunoassay
    Dip100 Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+ELISA+Kit/us12601747-328-9-26
    Average 96 stars, based on 1 article reviews
    dip100 quantikine immunoassay - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    human cxcl10 elisa kit  (R&D Systems)
    94
    R&D Systems human cxcl10 elisa kit
    The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
    Human Cxcl10 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+QuicKit+ELISA/pmc13046659-52-12-16
    Average 94 stars, based on 1 article reviews
    human cxcl10 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    duoset elisa kits  (R&D Systems)
    96
    R&D Systems duoset elisa kits
    The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
    Duoset Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+DuoSet+ELISA/pm41896548-400-9-16
    Average 96 stars, based on 1 article reviews
    duoset elisa kits - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    human cxcl10 elisa kit  (Elabscience Biotechnology)
    94
    Elabscience Biotechnology human cxcl10 elisa kit
    The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
    Human Cxcl10 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+IP-10%2FCXCL10+(Interferon+Gamma+Induced+Protein+10kDa)+ELISA+Kit/pm41813910-91-48-52
    Average 94 stars, based on 1 article reviews
    human cxcl10 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    quantikine elisa kit  (R&D Systems)
    96
    R&D Systems quantikine elisa kit
    The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
    Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+ELISA+Kit/pm41714683-112-29-27
    Average 96 stars, based on 1 article reviews
    quantikine elisa kit - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    cxcl10  (Proteintech)
    94
    Proteintech cxcl10
    The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
    Cxcl10, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+ELISA+Kit/pm41719890-162-12-14
    Average 94 stars, based on 1 article reviews
    cxcl10 - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    The differences in the expression and clinical correlation of CXCL10 were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: The differences in the expression and clinical correlation of CXCL10 were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Expressing, Immunohistochemistry

    The composition of cells in the breast cancer tissue microenvironment, interactions between cells, and differences in CXCL10 expression between breast cancer cells and T cells were analyzed with the single-cell sequencing data. ( A - B ) The composition of the main cells in the microenvironment of breast cancer tissue was analyzed with the NGDC database. ( C ) The interaction relationships between various types of cells were analyzed. ( D ) The CXCL10 expression levels were analyzed in various types of cells

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: The composition of cells in the breast cancer tissue microenvironment, interactions between cells, and differences in CXCL10 expression between breast cancer cells and T cells were analyzed with the single-cell sequencing data. ( A - B ) The composition of the main cells in the microenvironment of breast cancer tissue was analyzed with the NGDC database. ( C ) The interaction relationships between various types of cells were analyzed. ( D ) The CXCL10 expression levels were analyzed in various types of cells

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Expressing, Single Cell, Sequencing

    Correlation and differential expression analyses of CXCL10-interacting molecules were performed in BC. ( A ) CXCL10-interacting molecules were analyzed with the String database. ( B - E ) The correlations between CXCL10 and CCL13, CXCL6, PF4V1, and CXCL12 were analyzed with the GEPIA2 database. ( F - I ) Differences in the expression of CCL13, CXCL6, PF4V1 and CXCL12 in breast cancer were analyzed with the GEPIA2 database. ( J ) The differential expression of CXCL10 and CXCL12 in breast epithelial cells and breast cancer cells was detected by western blotting. (* p < 0.05)

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: Correlation and differential expression analyses of CXCL10-interacting molecules were performed in BC. ( A ) CXCL10-interacting molecules were analyzed with the String database. ( B - E ) The correlations between CXCL10 and CCL13, CXCL6, PF4V1, and CXCL12 were analyzed with the GEPIA2 database. ( F - I ) Differences in the expression of CCL13, CXCL6, PF4V1 and CXCL12 in breast cancer were analyzed with the GEPIA2 database. ( J ) The differential expression of CXCL10 and CXCL12 in breast epithelial cells and breast cancer cells was detected by western blotting. (* p < 0.05)

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Quantitative Proteomics, Expressing, Western Blot

    The differences in the expression and clinical correlation of CXCL12 were evaluated in BC patients. ( A ) Differences in CXCL12 expression in different types of breast cancer were analyzed with the TIMER2.0 database. ( B ) Based on GEPIA2 breast cancer data, a volcano map was drawn by bioinformatics to determine the expression of CXCL12. ( C ) Differences in the expression of CXCL12 in different clinical stages were analyzed with the GEPIA2 database. ( D ) The relationship between CXCL12 and the prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E - F ) The expression of CXCL12 in different types of cells was analyzed with single-cell sequencing from the NGDC database. ( G ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. (*** p < 0.001)

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: The differences in the expression and clinical correlation of CXCL12 were evaluated in BC patients. ( A ) Differences in CXCL12 expression in different types of breast cancer were analyzed with the TIMER2.0 database. ( B ) Based on GEPIA2 breast cancer data, a volcano map was drawn by bioinformatics to determine the expression of CXCL12. ( C ) Differences in the expression of CXCL12 in different clinical stages were analyzed with the GEPIA2 database. ( D ) The relationship between CXCL12 and the prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E - F ) The expression of CXCL12 in different types of cells was analyzed with single-cell sequencing from the NGDC database. ( G ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. (*** p < 0.001)

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Expressing, Single Cell, Sequencing, Immunohistochemistry

    The impact of CXCL12 on breast cancer and its correlation with CXCL10 were evaluated. ( A ) CXCL12 knockdown efficiency was detected by Q-PCR. ( B - C ) The impact of CXCL12 knockdown on cell invasion ability was detected by transwell assays. ( D - E ) The effect of CXCL12 knockdown on cell migration ability was detected by scratch assays. ( F ) The effect of CXCL12 knockdown on CXCL10 expression was detected by Q-PCR. ( G ) The effect of CXCL12 knockdown on CXCL10 secretion levels was detected by ELISA. (*** p < 0.001)

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: The impact of CXCL12 on breast cancer and its correlation with CXCL10 were evaluated. ( A ) CXCL12 knockdown efficiency was detected by Q-PCR. ( B - C ) The impact of CXCL12 knockdown on cell invasion ability was detected by transwell assays. ( D - E ) The effect of CXCL12 knockdown on cell migration ability was detected by scratch assays. ( F ) The effect of CXCL12 knockdown on CXCL10 expression was detected by Q-PCR. ( G ) The effect of CXCL12 knockdown on CXCL10 secretion levels was detected by ELISA. (*** p < 0.001)

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Knockdown, Migration, Expressing, Enzyme-linked Immunosorbent Assay

    Correlations between CXCL12 and CXCL10 and CD4 + T and CD8 + T cells in the inflammatory microenvironment of breast cancer patients were evaluated, and correlations with the clinical prognosis of breast cancer patients were evaluated. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) The expression levels of CXCL10 and CXCL12 in different types of T lymphocytes were analyzed in different types of breast cancer with the TIMER2.0 database. ( C - F ) The clinical prognosis under different conditions was analyzed with the TIMER2.0 database. ( G ) CD4 + T cells and CD8 + T cells in breast cancer tissues were analyzed by immunofluorescence

    Journal: Clinical and Experimental Medicine

    Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

    doi: 10.1007/s10238-026-02126-2

    Figure Lengend Snippet: Correlations between CXCL12 and CXCL10 and CD4 + T and CD8 + T cells in the inflammatory microenvironment of breast cancer patients were evaluated, and correlations with the clinical prognosis of breast cancer patients were evaluated. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) The expression levels of CXCL10 and CXCL12 in different types of T lymphocytes were analyzed in different types of breast cancer with the TIMER2.0 database. ( C - F ) The clinical prognosis under different conditions was analyzed with the TIMER2.0 database. ( G ) CD4 + T cells and CD8 + T cells in breast cancer tissues were analyzed by immunofluorescence

    Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

    Techniques: Expressing, Immunofluorescence